| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intraabdominal Infections | 12 | 2018 | 19 | 2.050 |
Why?
|
| Surgical Wound Infection | 8 | 2017 | 168 | 0.840 |
Why?
|
| Anti-Bacterial Agents | 11 | 2017 | 1026 | 0.800 |
Why?
|
| Ankle Injuries | 4 | 2011 | 16 | 0.790 |
Why?
|
| Subtalar Joint | 2 | 2011 | 6 | 0.710 |
Why?
|
| Ankle Joint | 3 | 2009 | 57 | 0.710 |
Why?
|
| Bone Screws | 3 | 2011 | 90 | 0.660 |
Why?
|
| Arthrodesis | 2 | 2008 | 21 | 0.610 |
Why?
|
| Abdominoplasty | 1 | 2015 | 1 | 0.530 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2015 | 20 | 0.530 |
Why?
|
| Micronutrients | 1 | 2015 | 31 | 0.520 |
Why?
|
| Serum Albumin | 1 | 2015 | 104 | 0.520 |
Why?
|
| Blood Proteins | 1 | 2015 | 94 | 0.510 |
Why?
|
| Calcaneus | 2 | 2011 | 8 | 0.470 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 172 | 0.450 |
Why?
|
| Wounds and Injuries | 4 | 2020 | 334 | 0.420 |
Why?
|
| Bone Plates | 2 | 2011 | 49 | 0.400 |
Why?
|
| Wounds, Penetrating | 2 | 2009 | 45 | 0.400 |
Why?
|
| Anti-Infective Agents | 3 | 2018 | 166 | 0.390 |
Why?
|
| Skin Transplantation | 1 | 2011 | 45 | 0.380 |
Why?
|
| Bone Transplantation | 1 | 2011 | 43 | 0.380 |
Why?
|
| Wounds, Gunshot | 2 | 2019 | 48 | 0.370 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2013 | 131 | 0.360 |
Why?
|
| Play and Playthings | 1 | 2009 | 22 | 0.340 |
Why?
|
| Adult | 32 | 2019 | 21379 | 0.330 |
Why?
|
| Firearms | 1 | 2009 | 26 | 0.330 |
Why?
|
| Cactaceae | 1 | 2008 | 1 | 0.330 |
Why?
|
| Humans | 52 | 2020 | 68549 | 0.330 |
Why?
|
| Joint Instability | 1 | 2009 | 87 | 0.320 |
Why?
|
| Mediastinum | 1 | 2008 | 39 | 0.320 |
Why?
|
| Retrospective Studies | 19 | 2017 | 7268 | 0.310 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 44 | 0.310 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2008 | 33 | 0.310 |
Why?
|
| Foreign Bodies | 1 | 2008 | 58 | 0.310 |
Why?
|
| Peroneal Neuropathies | 1 | 2007 | 2 | 0.300 |
Why?
|
| Bone Nails | 1 | 2007 | 32 | 0.300 |
Why?
|
| Curriculum | 3 | 2016 | 575 | 0.300 |
Why?
|
| Antibody Formation | 3 | 2013 | 93 | 0.300 |
Why?
|
| Multiple Trauma | 3 | 2011 | 50 | 0.280 |
Why?
|
| Arthroscopy | 2 | 2009 | 95 | 0.280 |
Why?
|
| Bacterial Infections | 3 | 2015 | 163 | 0.280 |
Why?
|
| Male | 32 | 2019 | 37283 | 0.280 |
Why?
|
| Clinical Competence | 3 | 2016 | 657 | 0.270 |
Why?
|
| General Surgery | 2 | 2016 | 95 | 0.260 |
Why?
|
| Braces | 1 | 2005 | 7 | 0.260 |
Why?
|
| Female | 33 | 2019 | 38021 | 0.250 |
Why?
|
| Middle Aged | 24 | 2019 | 21119 | 0.250 |
Why?
|
| Scoliosis | 1 | 2005 | 42 | 0.250 |
Why?
|
| Follow-Up Studies | 10 | 2016 | 3256 | 0.240 |
Why?
|
| B-Cell Activating Factor | 4 | 2013 | 12 | 0.240 |
Why?
|
| Brain Injuries | 3 | 2014 | 268 | 0.240 |
Why?
|
| Abdominal Injuries | 3 | 2011 | 60 | 0.240 |
Why?
|
| Forearm | 1 | 2004 | 25 | 0.230 |
Why?
|
| Hand | 1 | 2004 | 90 | 0.220 |
Why?
|
| Body Weight | 1 | 2005 | 554 | 0.220 |
Why?
|
| Wound Healing | 3 | 2015 | 260 | 0.220 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2013 | 41 | 0.210 |
Why?
|
| Sepsis | 2 | 2016 | 233 | 0.210 |
Why?
|
| Sports Medicine | 1 | 2002 | 22 | 0.210 |
Why?
|
| Expert Testimony | 1 | 2002 | 47 | 0.210 |
Why?
|
| Cerebrovascular Trauma | 2 | 2011 | 7 | 0.200 |
Why?
|
| Intracranial Hypertension | 2 | 2014 | 53 | 0.200 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2012 | 25 | 0.200 |
Why?
|
| Adolescent | 15 | 2018 | 8904 | 0.200 |
Why?
|
| Fellowships and Scholarships | 1 | 2002 | 127 | 0.200 |
Why?
|
| Orthopedics | 1 | 2002 | 88 | 0.190 |
Why?
|
| Aged | 16 | 2019 | 14842 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 2222 | 0.190 |
Why?
|
| B-Lymphocytes | 3 | 2013 | 329 | 0.190 |
Why?
|
| Injury Severity Score | 6 | 2014 | 204 | 0.190 |
Why?
|
| Wounds, Stab | 2 | 2011 | 7 | 0.180 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 225 | 0.180 |
Why?
|
| Trauma Centers | 4 | 2019 | 197 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 375 | 0.170 |
Why?
|
| Spinal Fractures | 2 | 2011 | 43 | 0.170 |
Why?
|
| Lymphocyte Activation | 2 | 2011 | 397 | 0.170 |
Why?
|
| Immunity, Innate | 2 | 2011 | 156 | 0.170 |
Why?
|
| Obesity | 2 | 2016 | 1074 | 0.160 |
Why?
|
| Treatment Outcome | 11 | 2017 | 7028 | 0.160 |
Why?
|
| Talus | 2 | 2009 | 18 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 2324 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2020 | 328 | 0.160 |
Why?
|
| Young Adult | 10 | 2018 | 5710 | 0.150 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 4843 | 0.150 |
Why?
|
| Drug Therapy | 1 | 2018 | 71 | 0.150 |
Why?
|
| Fibula | 2 | 2011 | 13 | 0.150 |
Why?
|
| Mycoses | 1 | 2018 | 60 | 0.150 |
Why?
|
| Cadaver | 2 | 2008 | 136 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2013 | 2004 | 0.140 |
Why?
|
| Debridement | 2 | 2014 | 55 | 0.140 |
Why?
|
| Decompressive Craniectomy | 2 | 2014 | 3 | 0.140 |
Why?
|
| Educational Measurement | 2 | 2015 | 254 | 0.140 |
Why?
|
| Laparotomy | 4 | 2017 | 65 | 0.140 |
Why?
|
| Intracranial Pressure | 2 | 2014 | 58 | 0.140 |
Why?
|
| Teaching Rounds | 1 | 2016 | 5 | 0.140 |
Why?
|
| Vancomycin | 1 | 2016 | 60 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 214 | 0.140 |
Why?
|
| Self-Assessment | 1 | 2016 | 69 | 0.130 |
Why?
|
| Biomechanical Phenomena | 2 | 2007 | 368 | 0.130 |
Why?
|
| Research Design | 1 | 2020 | 729 | 0.130 |
Why?
|
| Prospective Studies | 7 | 2019 | 3703 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2798 | 0.130 |
Why?
|
| Coinfection | 1 | 2015 | 29 | 0.130 |
Why?
|
| Preoperative Period | 1 | 2015 | 50 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 951 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 1465 | 0.130 |
Why?
|
| Competency-Based Education | 1 | 2015 | 32 | 0.130 |
Why?
|
| Spleen | 2 | 2013 | 301 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 92 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2011 | 3187 | 0.130 |
Why?
|
| Surgeons | 1 | 2016 | 68 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1046 | 0.130 |
Why?
|
| Granulomatous Mastitis | 1 | 2015 | 1 | 0.130 |
Why?
|
| Internship and Residency | 3 | 2016 | 596 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2015 | 25 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 156 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2016 | 249 | 0.120 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 567 | 0.120 |
Why?
|
| Recurrence | 5 | 2016 | 948 | 0.120 |
Why?
|
| Psychiatry | 1 | 2015 | 112 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 90 | 0.120 |
Why?
|
| Peritonitis | 2 | 2015 | 46 | 0.120 |
Why?
|
| Resuscitation | 1 | 2014 | 77 | 0.120 |
Why?
|
| Germinal Center | 1 | 2013 | 13 | 0.120 |
Why?
|
| Reoperation | 3 | 2011 | 467 | 0.120 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 438 | 0.120 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 5 | 0.120 |
Why?
|
| Splenic Artery | 1 | 2013 | 16 | 0.110 |
Why?
|
| Enoxaparin | 1 | 2013 | 51 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 103 | 0.110 |
Why?
|
| Fractures, Open | 2 | 2011 | 11 | 0.110 |
Why?
|
| Risk Factors | 8 | 2019 | 5720 | 0.110 |
Why?
|
| Fractures, Bone | 2 | 2011 | 132 | 0.110 |
Why?
|
| Weight Loss | 1 | 2015 | 319 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2015 | 331 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 772 | 0.110 |
Why?
|
| Treatment Failure | 3 | 2018 | 216 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 117 | 0.100 |
Why?
|
| Vertebral Artery | 1 | 2011 | 22 | 0.100 |
Why?
|
| Radiography | 2 | 2011 | 572 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.100 |
Why?
|
| Fractures, Ununited | 1 | 2011 | 16 | 0.100 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 150 | 0.100 |
Why?
|
| Fracture Healing | 1 | 2011 | 29 | 0.100 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 86 | 0.100 |
Why?
|
| Joint Dislocations | 1 | 2011 | 40 | 0.100 |
Why?
|
| Antigen Presentation | 1 | 2011 | 76 | 0.090 |
Why?
|
| Trauma Severity Indices | 4 | 2011 | 80 | 0.090 |
Why?
|
| Cell Communication | 1 | 2011 | 116 | 0.090 |
Why?
|
| APACHE | 3 | 2016 | 41 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2011 | 68 | 0.090 |
Why?
|
| Pentobarbital | 1 | 2010 | 19 | 0.090 |
Why?
|
| Coma | 1 | 2010 | 17 | 0.090 |
Why?
|
| Child | 6 | 2011 | 6401 | 0.090 |
Why?
|
| Free Tissue Flaps | 1 | 2011 | 67 | 0.090 |
Why?
|
| Equipment Failure Analysis | 2 | 2008 | 121 | 0.090 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2010 | 31 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 1 | 2010 | 55 | 0.090 |
Why?
|
| Device Removal | 1 | 2011 | 100 | 0.090 |
Why?
|
| Body Mass Index | 3 | 2016 | 866 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2010 | 8 | 0.090 |
Why?
|
| Buttocks | 1 | 2010 | 16 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 2077 | 0.090 |
Why?
|
| Thigh | 1 | 2010 | 27 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 30 | 0.090 |
Why?
|
| Joint Loose Bodies | 1 | 2009 | 4 | 0.090 |
Why?
|
| Delirium | 1 | 2010 | 45 | 0.090 |
Why?
|
| Collateral Ligaments | 1 | 2009 | 3 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.090 |
Why?
|
| Tendon Injuries | 1 | 2009 | 9 | 0.090 |
Why?
|
| Therapeutic Irrigation | 1 | 2010 | 63 | 0.090 |
Why?
|
| Case Management | 1 | 2010 | 46 | 0.090 |
Why?
|
| Abdomen | 1 | 2010 | 80 | 0.090 |
Why?
|
| Southwestern United States | 1 | 2009 | 5 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2010 | 98 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2009 | 38 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2011 | 201 | 0.090 |
Why?
|
| Burns | 1 | 2010 | 83 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 766 | 0.080 |
Why?
|
| Morbidity | 1 | 2009 | 130 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2009 | 164 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 57 | 0.080 |
Why?
|
| Accidents, Home | 1 | 2008 | 9 | 0.080 |
Why?
|
| Pliability | 1 | 2008 | 8 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 319 | 0.080 |
Why?
|
| Time Factors | 4 | 2019 | 4655 | 0.080 |
Why?
|
| Weight-Bearing | 1 | 2008 | 53 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 1213 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.080 |
Why?
|
| Pancreas | 1 | 2009 | 225 | 0.080 |
Why?
|
| Consensus | 2 | 2020 | 211 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 52 | 0.070 |
Why?
|
| Ligaments, Articular | 1 | 2007 | 21 | 0.070 |
Why?
|
| Telemedicine | 1 | 2015 | 699 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1034 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 112 | 0.070 |
Why?
|
| Tibia | 1 | 2007 | 93 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2008 | 237 | 0.070 |
Why?
|
| Blepharoplasty | 1 | 2006 | 3 | 0.070 |
Why?
|
| Infant | 2 | 2011 | 2891 | 0.070 |
Why?
|
| Homeostasis | 1 | 2008 | 291 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2006 | 75 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 536 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 201 | 0.070 |
Why?
|
| Registries | 1 | 2009 | 730 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 551 | 0.070 |
Why?
|
| Emergency Treatment | 1 | 2005 | 52 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1533 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 911 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2019 | 306 | 0.060 |
Why?
|
| Operating Rooms | 1 | 2005 | 108 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.060 |
Why?
|
| Polyglactin 910 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2012 | 2791 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2005 | 115 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 55 | 0.060 |
Why?
|
| Hernia, Ventral | 1 | 2004 | 35 | 0.060 |
Why?
|
| Polypropylenes | 1 | 2004 | 31 | 0.060 |
Why?
|
| Surgical Mesh | 1 | 2004 | 57 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2004 | 83 | 0.060 |
Why?
|
| Intestinal Perforation | 1 | 2002 | 35 | 0.050 |
Why?
|
| Spondylolisthesis | 1 | 2002 | 20 | 0.050 |
Why?
|
| Foot Injuries | 1 | 2002 | 1 | 0.050 |
Why?
|
| Mice | 5 | 2013 | 8474 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1419 | 0.050 |
Why?
|
| Leg Injuries | 1 | 2002 | 18 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 1425 | 0.050 |
Why?
|
| Animals | 7 | 2013 | 20880 | 0.050 |
Why?
|
| Colon | 1 | 2002 | 168 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2012 | 53 | 0.050 |
Why?
|
| Spinal Fusion | 1 | 2002 | 90 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 694 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2013 | 242 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2002 | 239 | 0.050 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 2 | 2013 | 4 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2002 | 120 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 1860 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2020 | 62 | 0.050 |
Why?
|
| Incidence | 2 | 2016 | 1582 | 0.040 |
Why?
|
| Exsanguination | 1 | 2019 | 8 | 0.040 |
Why?
|
| Survival Rate | 2 | 2013 | 1055 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 1033 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 84 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 241 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1851 | 0.040 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 105 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 38 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2020 | 310 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1140 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 44 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2016 | 64 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 65 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 2356 | 0.030 |
Why?
|
| Drainage | 1 | 2016 | 133 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2015 | 13 | 0.030 |
Why?
|
| Problem-Based Learning | 1 | 2016 | 72 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 563 | 0.030 |
Why?
|
| Accreditation | 1 | 2015 | 72 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Arizona | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prognosis | 2 | 2011 | 2093 | 0.030 |
Why?
|
| Appendicitis | 1 | 2015 | 55 | 0.030 |
Why?
|
| Fever | 1 | 2015 | 96 | 0.030 |
Why?
|
| Cross Infection | 1 | 2016 | 195 | 0.030 |
Why?
|
| Teaching | 1 | 2016 | 169 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 737 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 26 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1753 | 0.030 |
Why?
|
| Factor Xa | 1 | 2013 | 10 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 403 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 502 | 0.030 |
Why?
|
| Propensity Score | 1 | 2014 | 116 | 0.030 |
Why?
|
| Students, Medical | 1 | 2016 | 210 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 714 | 0.030 |
Why?
|
| Factor Xa Inhibitors | 1 | 2013 | 43 | 0.030 |
Why?
|
| Splenectomy | 1 | 2013 | 40 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2013 | 82 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 489 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 507 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 16 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 1341 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2012 | 97 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 424 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2015 | 335 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2011 | 110 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 151 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 120 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Cilastatin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Imipenem | 1 | 2010 | 9 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 100 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2010 | 15 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2013 | 356 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 126 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 124 | 0.020 |
Why?
|
| Methadone | 1 | 2010 | 32 | 0.020 |
Why?
|
| Levofloxacin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Tobramycin | 1 | 2010 | 38 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2010 | 65 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 658 | 0.020 |
Why?
|
| Back Injuries | 1 | 2010 | 1 | 0.020 |
Why?
|
| Colostomy | 1 | 2010 | 15 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 226 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 133 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 532 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 977 | 0.020 |
Why?
|
| Off-Label Use | 1 | 2010 | 17 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 304 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2010 | 130 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2265 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 163 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 190 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 109 | 0.020 |
Why?
|
| Critical Illness | 1 | 2010 | 191 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2009 | 76 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 334 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2008 | 75 | 0.020 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2008 | 1 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2010 | 344 | 0.020 |
Why?
|
| B-Cell Activation Factor Receptor | 1 | 2008 | 3 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 410 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 880 | 0.020 |
Why?
|
| United States | 2 | 2011 | 7338 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 411 | 0.020 |
Why?
|
| Indians, North American | 1 | 2008 | 64 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 89 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1329 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2008 | 112 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1609 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2673 | 0.020 |
Why?
|
| Contrast Media | 1 | 2009 | 595 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2010 | 498 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2005 | 172 | 0.020 |
Why?
|
| Tennessee | 1 | 2004 | 11 | 0.020 |
Why?
|
| Cutaneous Fistula | 1 | 2004 | 11 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 70 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2004 | 130 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2002 | 145 | 0.010 |
Why?
|
| Tibial Fractures | 1 | 2002 | 25 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 168 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2004 | 281 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 239 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 465 | 0.010 |
Why?
|